The Risk of Toxicities from Trastuzumab, Alone or in Combination, in an Elderly Breast Cancer Population-Reference-Cited by-同舟云学术

The Risk of Toxicities from Trastuzumab, Alone or in Combination, in an Elderly Breast Cancer Population

Published:2014 Issue:1 Volume:86 Page:16-21
ISSN:1423-0232
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Adamo Vincenzo,Ricciardi Giuseppina Rosaria Rita,Adamo Barbara,Ferraro Giuseppa,Franchina Tindara,Rossello Rosalba,Zanghì Mariangela,Cicero Giuseppe,Rizzo Sergio,Caristi Nicola,Russo Antonio

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2‐Positive Breast Cancer;International Journal of Breast Cancer;2024-01

2. Preventive effect of dexamethasone premedication on the development of infusion‐related reaction in breast cancer patients receiving trastuzumab;British Journal of Clinical Pharmacology;2023-02-09

3. Treatment results and patient characeristics for breast cancer patients older than 70 Years;Medical Science and Discovery;2022-03-01

4. Conventional cardiac risk factors associated with trastuzumab-induced cardiotoxicity in breast cancer: Systematic review and meta-analysis;Current Problems in Cancer;2021-10

5. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the C ardio‐ O ncology S tudy G roup of the H eart F ailure A ssociation of the E uropean S ociety of C ardiology in collaboration with the I nternational C ardio‐ O ncology S ociety;European Journal of Heart Failure;2020-08-06